drugset / Trial / NCT01171755
Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer
NaSingle-groupOpen-labelTreatment
Summary
In current study, we evaluate the efficacy of gemcitabine and TS-1 combination chemotherapy in advanced BTC.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-12
- Completion
- 2009-12
Outcome
Outcome not reported
Stopped: “The objective response rate by more than two people are confirmed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | TS-1 | Small molecule | 80 mg | Oral |
| Subject | TS-1 | Small molecule | 100 mg | Oral |
| Subject | TS-1 | Small molecule | 120 mg | Oral |